WashU researchers honored with NIH Director’s Awards
Three WashU investigators have been recognized with prestigious awards through the National Institutes of Health (NIH) Director’s High-Risk, High-Reward Research program, which supports unconventional approaches to major challenges in biomedical and behavioral research.
Researchers find key to stopping deadly infection
New research from WashU Medicine identified a key enzyme that enables rotavirus to infect cells. Disabling this enzyme prevented infection, suggesting new treatments against rotavirus and other pathogens that rely on similar mechanisms.
An inside look at the earliest stage of life
Researchers at Washington University in St. Louis have a developed a way to monitor mouse embryo development and predict successful blastocyst formation. The results of the study could help improve success rates of in vitro fertilization.
Implementing science across borders
WashU’s Prevention Research Center delivered its Evidence-Based Public Health training in Puerto Rico, strengthening local health workforce capacity to tackle chronic disease and limited resources.
Circadian clock protein linked to brain aging, neurodegenerative disease
WashU Medicine researchers led by Erik Musiek, MD, PhD, discovered in mice that inhibition of a protein that controls the daily cycling of metabolism and inflammation decreases neurodegeneration in Alzheimer’s disease.
Body’s garbage-collecting cells protect insulin production in pancreas
WashU Medicine researchers found that immune cells that dispose of the body’s cellular debris can protect insulin-producing cells and prevent Type 1 diabetes in mice.
Multidisciplinary team secures $3.6M grant to investigate health risks from flooding
Funding from the National Science Foundation will enable researchers across many disciplines at Washington University in St. Louis to advance ongoing research into the damaging health effects of repeated flooding in Metro East communities.
Personalized brain modeling of anesthetic effects to predict antidepressant response
Neuroscientists, clinicians and engineers at Washington University in St. Louis seek to develop personalized medicine strategies for refractory depression that would tailor drug dosage based on a patient’s age, genetics, health conditions, brain dynamics and neural circuits.
Novel technologies underway to help those with spinal cord injuries move
A multidisciplinary team of researchers at Washington University in St. Louis plans to investigate the neural mechanisms behind various controls of transcutaneous spinal cord stimulation in generating different leg movements with a five-year, nearly $3 million grant the National Institutes of Health (NIH).
Dai receives $200,000 grant from Alzheimer’s Association
A scientist at Washington University in St. Louis has received a grant from the Alzheimer’s Association to support his research investigating the electrochemistry of neurotoxic protein assemblies.
Older Stories